Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Mar 22, 2024 · 10-K · 82 days after period end · 0001615219-24-000025
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $1.48M |
| Net Income | -$881.80K | -$6.37M | -$4.10M | -$1.77M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 22, 2024 · 82 d after period end
